A Focus On Science
NRG Oncology (nrgoncology.org) scores 75 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, Non-profit brands, Education brands, in the 46th percentile of 19412 Healthcare brands.
NRG Oncology is a nonprofit cancer research organization based in Philadelphia, United States, that conducts practice-defining, multi-institutional phase I, II, and III clinical trials, primarily sponsored by the National Cancer Institute (NCI). Drawing on more than 150 years of combined experience among its partners, the organization also undertakes translational biological studies aimed at advancing future cancer care. Its work supports oncology researchers, clinical investigators, medical institutions, and cancer patients involved in clinical research.
| Brand Name | NRG Oncology |
|---|---|
| Domain | nrgoncology.org |
| Industry | Healthcare, Non-profit |
| Headquarters | Philadelphia, United States |
| Main Competitors | SWOG Cancer Research Network (76/100), Alliance for Clinical Trials in Oncology (68/100), ECOG-ACRIN Cancer Research Group (78/100), Children's Oncology Group (85/100), Canadian Cancer Trials Group, NRG Oncology's historical predecessor RTOG Foundation (78/100) |
Moz Domain Authority 44/100 vs category average 40 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #1,561,333 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "A Focus On Science NRG Oncology and its partners have more than 150 years experience in conducting practice-defining, multi-institutional phase II and III trial…" (No meta description. OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare, WordPress, Ghost, React.
Social footprint: verified profiles on X (Twitter), Facebook, Instagram, LinkedIn, YouTube; no detected presence on GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is NRG Oncology?", Claude could identify the brand as of October 2026. NRG Oncology is a nonprofit clinical research organization that designs and conducts cancer clinical trials, formed from the merger of the National Surgical Adjuvant Breast and Bowel Project (NSABP), the Radiation Therapy Oncology Group (RTOG), and the Gynecologic Oncology Group Best known for Conducting large-scale, multi-institutional cancer clinical trials, especially in radiation oncology, gynecologic cancers, and breast/colorectal cancer.
When asked "Best brands similar to NRG Oncology?", Claude would recommend NRG Oncology as of October 2026. It's a major NCI-affiliated cooperative group and a natural mention if someone asks about leading cancer clinical trial networks or oncology research organizations.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
NRG Oncology's main competitors in Healthcare: SWOG Cancer Research Network (76/100), Alliance for Clinical Trials in Oncology (68/100), ECOG-ACRIN Cancer Research Group (78/100), Children's Oncology Group (85/100), NRG Oncology's historical predecessor RTOG Foundation (78/100).
Sources: Brand Analyzer scan
NRG Oncology has limited AI-search visibility, scoring 43/100 on Brand Analyzer's AI visibility composite (visibility 21, trust 58, recommendation 63). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: NRG Oncology official site
NRG Oncology scores 63/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: NRG Oncology official site
NRG Oncology is a nonprofit cancer research organization headquartered in Philadelphia, United States. It functions as a cooperative clinical trials group, primarily sponsored by the National Cancer Institute (NCI), that designs and conducts multi-institutional phase I, II, and III cancer clinical trials as well as translational research studies.
Sources: NRG Oncology official site
NRG Oncology conducts practice-defining, multi-institutional phase II and III clinical trials, as well as phase I trials and translational biological studies, primarily sponsored by the National Cancer Institute. These efforts are aimed at advancing scientific understanding of cancer and shaping future standards of oncology care.
Sources: NRG Oncology official site
NRG Oncology can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: NRG Oncology official site
NRG Oncology offers multi-institutional phase I, II, and III clinical trials in oncology, along with translational biological studies. These research services are primarily sponsored by the National Cancer Institute and are designed to generate findings that influence future cancer treatment standards.
Sources: NRG Oncology official site
NRG Oncology is known for conducting large-scale, multi-institutional cancer clinical trials sponsored primarily by the National Cancer Institute, drawing on more than 150 years of combined experience among its partner institutions in phase II, III, and translational cancer research.
Sources: NRG Oncology official site
NRG Oncology scores 43/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
NRG Oncology has a limited AI-visibility profile at 43/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (63/100) and its weakest is visibility (21/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #1,561,333 (Tranco) and a Moz Domain Authority of 44/100. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify NRG Oncology from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to NRG Oncology: National PACE Association (NPA) (75/100), NovoBiotic Pharmaceuticals (75/100), Nova Scotia Regulator of Dietetics (75/100), Stichting het Gehandicapte Kind (75/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.